Who owns Amicus Therapeutics?

Key details on Amicus Therapeutics (Ticker: FOLD)

Who owns Amicus Therapeutics?

Is FOLD a good stock to own? Find out who bought Amicus Therapeutics, who sold Amicus Therapeutics (FOLD) stock, and who holds a large position in Amicus Therapeutics.

Fund Name Number of Shares Share Valuation As Of
Perceptive Advisors 12.34M $73.42M Sept. 30, 2014
Redmile 5.71M $33.96M Sept. 30, 2014
NEA Management Company 5.65M $33.64M Sept. 30, 2014
HealthCor Management 2.28M $6.11M Dec. 31, 2012
Palo Alto Investors 1.96M $11.64M Sept. 30, 2014
Franklin Resources 1.87M $11.14M Sept. 30, 2014
Vanguard 1.77M $10.53M Sept. 30, 2014
Bridger Management 1.71M $9.01M March 31, 2012
Dr. Jeffrey R. Jay, M.D 1.64M $5.64M Dec. 31, 2011
D. E. Shaw & Co 1.51M $8.96M Sept. 30, 2014
Millennium Management 1.48M $8.81M Sept. 30, 2014
Wellington Management Company 1.42M $3.31M June 30, 2013
RS INVESTMENT MANAGEMENT 1.25M $7.43M Sept. 30, 2014
BOGLE INVESTMENT MANAGEMENT L P /DE/ 1.23M $7.33M Sept. 30, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 986000 $5.87M Sept. 30, 2014
BlackRock Fund Advisors 854639 $1.77M March 31, 2014
Austin W. Marxe and David M. Greenhouse 821466 $4.27M Sept. 30, 2012
MORGAN STANLEY 674039 $4.01M Sept. 30, 2014
Sound Energy Partners 663716 $2.22M June 30, 2014
Eudaimonia Asset Management 612199 $3.64M Sept. 30, 2014
Visium Asset Management 605731 $3.60M Sept. 30, 2014
Ghost Tree Capital 600000 $2.00M June 30, 2014
Technical Financial Services 586651 $1.38M Dec. 31, 2013
FMR 562204 $3.35M Sept. 30, 2014
Samlyn Capital 550000 $3.02M June 30, 2012
NUMERIC INVESTORS 524542 $3.12M Sept. 30, 2014
Royce & Associates 515700 $1.20M Sept. 30, 2013
Driehaus Capital Management 513523 $1.63M March 31, 2013
Balyasny Asset Management 512284 $1.20M Dec. 31, 2013
Baker Bros. Advisors 481697 $2.87M Sept. 30, 2014
Deerfield Management Company 480000 $2.86M Sept. 30, 2014
Bailard 468000 $1.48M March 31, 2013
PUTNAM INVESTMENTS 452200 $0 Sept. 30, 2014
STATE STREET CORPORATION 451463 $1.21M Dec. 31, 2013
JANE STREET 446057 $1.49M June 30, 2014

Who sold Amicus Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Global Endowment Management Dec. 31, 2010 668448 $3.08M